Neurobiology of vascular dementia

Journal of Aging Research

Volumn 2011, Issue , 2011, Pages

  Enciu, Ana Maria ^a   Constantinescu, Stefan N ^a,b   Popescu, Laureniu M ^a,c   Mureşanu, Dafin F ^d   Popescu, Bogdan O ^a,c,e  

^a CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^b DE DUVE INSTITUTE   (Belgium)

^c VICTOR BABES NATIONAL INSTITUTE OF PATHOLOGY   (Romania)

^d IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^e ST ANNE S UNIVERSITY HOSPITAL   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUCOSE TRANSPORTER 1; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 6; LACTATE DEHYDROGENASE; MITOCHONDRIAL DNA; NITRIC OXIDE SYNTHASE; PROTEIN P55; PROTEIN P75; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

AGING; ALZHEIMER DISEASE; BRAIN ATROPHY; BRAIN BLOOD FLOW; BRAIN DISEASE; BRAIN ISCHEMIA; CEREBROVASCULAR DISEASE; CYTOKINE PRODUCTION; DEGENERATIVE DISEASE; ENDOTHELIAL DYSFUNCTION; ENZYME ACTIVITY; HUMAN; MIXED DEPRESSION AND DEMENTIA; MOLECULAR DIAGNOSIS; MULTIINFARCT DEMENTIA; NERVE CELL NECROSIS; NERVE CELL NETWORK; NEUROBIOLOGY; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; RISK FACTOR;

EID: 84857133627     PISSN: 20902204     EISSN: 20902212     Source Type: Journal    
DOI: 10.4061/2011/401604     Document Type: Review

References (127)

1. Iemolo F., Duro G., Rizzo C., Castiglia L., Hachinski V., Caruso C., Pathophysiology of vascular dementia. Immunity & Ageing 2009 6 13
2. Pearce J. M., Johann Jakob Wepfer (1620-95) and cerebral haemorrhage. Journal of Neurology, Neurosurgery and Psychiatry 1997 62 4 387 2-s2.0-0031111357
3. Mast H., Tatemichi T. K., Mohr J. P., Chronic brain ischemia: the contributions of Otto Binswanger and Alois Alzheimer to the mechanisms of vascular dementia. Journal of the Neurological Sciences 1995 132 supplement 1 4 10 2-s2.0-0029048292 10.1016/0022-510X(95)00116-J
4. Román G., Vascular dementia: a historical background. International Psychogeriatrics 2003 15 1 11 13 2-s2.0-0141819911
5. Hachinski V. C., Iliff L. D., Zilhka E., Cerebral blood flow in dementia. Archives of Neurology 1975 32 9 632 637
6. Hachinski V. C., The decline and resurgence of vascular dementia. Canadian Medical Association Journal 1990 142 2 107 111 2-s2.0-0025176497
7. Konno S., Sterling Meyer J., Terayama Y., Margishvili G. M., Mortel K. F., Classification, diagnosis and treatment of vascular dementia. Drugs and Aging 1997 11 5 361 373 2-s2.0-0030773732
8. Moretti A., Gorini A., Villa R. F., Pharmacotherapy and prevention of vascular dementia. CNS & Neurological Disorders-Drug Targets 2011 10 3 370 390
9. Stewart R., Vascular dementia: a diagnosis running out of time. British Journal of Psychiatry 2002 180 152 156 2-s2.0-0036163065 10.1192/bjp.180.2.152
10. Cacabelos R., Fernandez-Novoa L., Perez-Trullen J. M., Franco-Maside A., Alvarez X. A., Serum histamine in Alzheimer's disease and multi-infarct dementia. Methods and Findings in Experimental and Clinical Pharmacology 1992 14 9 711 715 2-s2.0-0027082590
11. Schneck M. J., Vascular dementia. Topics in Stroke Rehabilitation 2008 15 1 22 26 2-s2.0-38549141738 10.1310/tsr1501-22
12. Loeb C., Gandolfo C., Diagnostic evaluation of degenerative and vascular dementia. Stroke 1983 14 3 399 401 2-s2.0-0020638387
13. Roman G. C., Tatemichi T. K., Erkinjuntti T., Cummings J. L., Masdeu J. C., Garcia J. H., Amaducci L., Orgogozo J. M., Brun A., Hofman A., Moody D. M., O'Brien M. D., Yamaguchi T., Grafman J., Drayer B. P., Bennett D. A., Fisher M., Ogata J., Kokmen E., Vascular dementia: diagnostic criteria for research studies: report of the NINDS-AIREN International Workshop. Neurology 1993 43 2 250 260 2-s2.0-0027534657
14. Pohjasvaara T., Mantyla R., Ylikoski R., Kaste M., Erkinjuntti T., Comparison of different clinical criteria (DSM-III, ADDTC, ICD-10, NINDS-AIREN, DSM-IV) for the diagnosis of vascular dementia. National Institute of Neurological Disorders and Stroke. Stroke 2000 31 12 2952 2957
15. Sturrock R. R., A quantitative lifespan study of changes in cell number, cell division and cell death in various regions of the mouse forebrain. Neuropathology and Applied Neurobiology 1979 5 6 433 456 2-s2.0-0018613767
16. Terry R. D., DeTeresa R., Hansen L. A., Neocortical cell counts in normal human adult aging. Annals of Neurology 1987 21 6 530 539 2-s2.0-0023276014
17. Vincent S. L., Peters A., Tigges J., Effects of aging on the neurons within area 17 of rhesus monkey cerebral cortex. Anatomical Record 1989 223 3 329 341 2-s2.0-0024510960
18. Merrill D. A., Roberts J. A., Tuszynski M. H., Conservation of neuron number and size in entorhinal cortex layers II, III, and V/VI of aged primates. Journal of Comparative Neurology 2000 422 3 396 401 2-s2.0-0034601285 10.1002/1096-9861(20000703)422:3396::AID-CNE6>3.0.CO;2-R
19. Peters A., Leahu D., Moss M. B., McNally K. J., The effects of aging on area 46 of the frontal cortex of the rhesus monkey. Cerebral Cortex 1994 4 6 621 635 2-s2.0-0028568245
20. Gazzaley A. H., Thakker M. M., Hof P. R., Morrison J. H., Preserved number of entorhinal cortex layer II neurons in aged macaque monkeys. Neurobiology of Aging 1997 18 5 549 553 2-s2.0-0030713391 10.1016/S0197-4580(97) 00112-7
21. Soininen H., Puranen M., Riekkinen P. J., Computed tomography findings in senile dementia and normal aging. Journal of Neurology Neurosurgery and Psychiatry 1982 45 1 50 54 2-s2.0-0020065726
22. Scahill R. I., Frost C., Jenkins R., Whitwell J. L., Rossor M. N., Fox N. C., A longitudinal study of brain volume changes in normal aging using serial registered magnetic resonance imaging. Archives of Neurology 2003 60 7 989 994 2-s2.0-0038375823 10.1001/archneur.60.7.989
23. Mungas D., Harvey D., Reed B. R., Jagust W. J., DeCarli C., Beckett L., Mack W. J., Kramer J. H., Weiner M. W., Schuff N., Chui H. C., Longitudinal volumetric MRI change and rate of cognitive decline. Neurology 2005 65 4 565 571 2-s2.0-23844442499 10.1212/01.wnl.0000172913.88973.0d
24. Freeman S. H., Kandel R., Cruz L., Rozkalne A., Newell K., Frosch M. P., Hedley-Whyte E. T., Locascio J. J., Lipsitz L. A., Hyman B. T., Preservation of neuronal number despite age-related cortical brain atrophy in elderly subjects without Alzheimer disease. Journal of Neuropathology and Experimental Neurology 2008 67 12 1205 1212 2-s2.0-58149399367 10.1097/NEN.0b013e31818fc72f
25. Grill J. D., Riddle D. R., Age-related and laminar-specific dendritic changes in the medial frontal cortex of the rat. Brain Research 2002 937 1-2 8 21 2-s2.0-0037165871 10.1016/S0006-8993(02)02457-5
26. de Brabander J. M., Kramers R. J., Uylings H. B., Layer-specific dendritic regression of pyramidal cells with ageing in the human prefrontal cortex. European Journal of Neuroscience 1998 10 4 1261 1269 2-s2.0-0031824046 10.1046/j.1460-9568.1998.00137.x
27. Uylings H. B. M., De Brabander J. M., Neuronal changes in normal human aging and Alzheimer's disease. Brain and Cognition 2002 49 3 268 276 2-s2.0-0036343699 10.1006/brcg.2001.1500
28. Dickstein D. L., Kabaso D., Rocher A. B., Luebke J. I., Wearne S. L., Hof P. R., Changes in the structural complexity of the aged brain. Aging Cell 2007 6 3 275 284 2-s2.0-34249025187 10.1111/j.1474-9726.2007.00289.x
29. Burke S. N., Barnes C. A., Neural plasticity in the ageing brain. Nature Reviews Neuroscience 2006 7 1 30 40 2-s2.0-29244439038 10.1038/nrn1809
30. Rapp P. R., Gallagher M., Preserved neuron number in the hippocampus of aged rats with spatial learning deficits. Proceedings of the National Academy of Sciences of the United States of America 1996 93 18 9926 9930 2-s2.0-0029821150 10.1073/pnas.93.18.9926
31. Kennedy K. M., Raz N., Pattern of normal age-related regional differences in white matter microstructure is modified by vascular risk. Brain Research 2009 1297 41 56 2-s2.0-71749116405 10.1016/j.brainres.2009.08.058
32. Kramer J. H., Mungas D., Reed B. R., Wetzel M. E., Burnett M. M., Miller B. L., Weiner M. W., Chui H. C., Longitudinal MRI and cognitive change in healthy elderly. Neuropsychology 2007 21 4 412 418 2-s2.0-34548177027 10.1037/0894-4105.21.4.412
33. Toescu E. C., Normal brain ageing: models and mechanisms. Philosophical Transactions of the Royal Society B 2005 360 1464 2347 2354 2-s2.0-33745287476 10.1098/rstb.2005.1771
34. Ames B. N., Shigenaga M. K., Hagen T. M., Oxidants, antioxidants, and the degenerative diseases of aging. Proceedings of the National Academy of Sciences of the United States of America 1993 90 17 7915 7922 2-s2.0-0027171266
35. Brunk U. T., Terman A., The mitochondrial-lysosomal axis theory of aging: accumulation of damaged mitochondria as a result of imperfect autophagocytosis. European Journal of Biochemistry 2002 269 8 1996 2002 2-s2.0-0036236006 10.1046/j.1432-1033.2002.02869.x
36. Toescu E. C., Verkhratsky A., Parameters of calcium homeostasis in normal neuronal ageing. Journal of Anatomy 2000 197 4 563 569 2-s2.0-0034526675 10.1017/S0021878299006470
37. Cohen R. A., Hypertension and cerebral blood flow: implications for the development of vascular cognitive impairment in the elderly. Stroke 2007 38 6 1715 1717 2-s2.0-34249825212 10.1161/STROKEAHA.107.487165
38. Matsuda H., Maeda T., Yamada M., Age-matched normal values and topographic maps for regional cerebral blood flow measurements by Xe-133 inhalation. Stroke 1984 15 2 336 342 2-s2.0-0021326621
39. Iadecola C., Park L., Capone C., Threats to the mind: aging, amyloid, and hypertension. Stroke 2009 40 3 S40 S44 2-s2.0-62949149460 10.1161/STROKEAHA. 108.533638
40. Pirson A. S., Vander Borght T., Van Laere K., Age and gender effects on normal regional cerebral blood flow. American Journal of Neuroradiology 2006 27 6 1161 1162 2-s2.0-33747401656
41. Zhou H., Saidel G. M., Lamanna J. C., Cerebral blood flow adaptation to chronic hypoxia. Advances in Experimental Medicine and Biology 2008 614 371 377 2-s2.0-41649086393 10.1007/978-0-387-74911-2-41
42. Ritz M. F., Fluri F., Engelter S. T., Schaeren-Wiemers N., Lyrer P. A., Cortical and putamen age-related changes in the microvessel density and astrocyte deficiency in spontaneously hypertensive and stroke-prone spontaneously hypertensive rats. Current Neurovascular Research 2009 6 4 279 287 2-s2.0-70350339344 10.2174/156720209789630311
43. Angelopoulos P., Agouridaki H., Vaiopoulos H., Siskou E., Doutsou K., Costa V., Baloyiannis S. I., Cytokines in Alzheimer's disease and vascular dementia. International Journal of Neuroscience 2008 118 12 1659 1672 2-s2.0-54349118956 10.1080/00207450701392068
44. Campbell I. L., Hofer M. J., Pagenstecher A., Transgenic models for cytokine-induced neurological disease. Biochimica et Biophysica Acta 2009 1802 10 903 917
45. Campbell I. L., Stalder A. K., Akwa Y., Pagenstecher A., Asensio V. C., Transgenic models to study the actions of cytokines in the central nervous system. NeuroImmunoModulation 1998 5 3-4 126 135 2-s2.0-0031713845 10.1159/000026329
46. Akassoglou K., Bauer J., Kassiotis G., Pasparakis M., Lassmann H., Kollias G., Probert L., Oligodendrocyte apoptosis and primary demyelination induced by local TNF/p55TNF receptor signaling in the central nervous system of transgenic mice: models for multiple sclerosis with primary oligodendrogliopathy. American Journal of Pathology 1998 153 3 801 813 2-s2.0-0031659763
47. Batti L., O'Connor J. J., Tumor necrosis factor- α impairs the recovery of synaptic transmission from hypoxia in rat hippocampal slices. Journal of Neuroimmunology 2010 218 1-2 21 27 2-s2.0-73149103459 10.1016/j.jneuroim.2009.11.002
48. Ginis I., Hallenbeck J. M., Liu J., Spatz M., Jaiswal R., Shohami E., Tumor necrosis factor and reactive oxygen species cooperative cytotoxicity is mediated via inhibition of NF-kappaB. Molecular Medicine 2000 6 12 1028 1041 2-s2.0-0034574885
49. Farfara D., Lifshitz V., Frenkel D., Neuroprotective and neurotoxic properties of glial cells in the pathogenesis of Alzheimer's disease: Alzheimer's Review Series. Journal of Cellular and Molecular Medicine 2008 12 3 762 780 2-s2.0-44149083565 10.1111/j.1582-4934.2008.00314.x
50. Zuliani G., Cavalieri M., Galvani M., Passaro A., Munari M. R., Bosi C., Zurlo A., Fellin R., Markers of endothelial dysfunction in older subjects with late onset Alzheimer's disease or vascular dementia. Journal of the Neurological Sciences 2008 272 1-2 164 170 2-s2.0-48349091599 10.1016/j.jns.2008.05.020
51. Zhang R. L., Chopp M., Zhang Z. G., Phillips M. L., Rosenbloom C. L., Cruz R., Manning A., E-selectin in focal cerebral ischemia and reperfusion in the rat. Journal of Cerebral Blood Flow and Metabolism 1996 16 6 1126 1136 2-s2.0-19244364354
52. Wakita H., Ruetzler C., Illoh K. O., Chen Y., Takanohashi A., Spatz M., Hallenbeck J. M., Mucosal tolerization to E-selectin protects against memory dysfunction and white matter damage in a vascular cognitive impairment model. Journal of Cerebral Blood Flow and Metabolism 2008 28 2 341 353 2-s2.0-38549090260 10.1038/sj.jcbfm.9600528
53. Hu D., Serrano F., Oury T. D., Klann E., Aging-dependent alterations in synaptic plasticity and memory in mice that overexpress extracellular superoxide dismutase. Journal of Neuroscience 2006 26 15 3933 3941 2-s2.0-33646101468 10.1523/JNEUROSCI.5566-05.2006
54. Popa-Wagner A., Buga A. M., Kokaia Z., Perturbed cellular response to brain injury during aging. Ageing Research Reviews 2011 10 1 71 79 2-s2.0-78650230589 10.1016/j.arr.2009.10.008
55. Canuelo A., Siles E., Martinez-Romero R., Peinado M. A., Martinez-Lara E., The nitric oxide system response to hypoxia/reoxygenation in the aged cerebral cortex. Experimental Gerontology 2007 42 12 1137 1145
56. Mander P., Brown G. C., Nitric oxide, hypoxia and brain inflammation. Biochemical Society Transactions 2004 32 6 1068 1069 2-s2.0-10644287654 10.1042/BST0321068
57. Scorziello A., Pellegrini C., Secondo A., Sirabella R., Formisano L., Sibaud L., Amoroso S., Canzoniero L. M. T., Annunziato L., Di Renzo G. F., Neuronal NOS activation during oxygen and glucose deprivation triggers cerebellar granule cell death in the later reoxygenation phase. Journal of Neuroscience Research 2004 76 6 812 821 2-s2.0-2642559679 10.1002/jnr.20096
58. Adibhatla R. M., Hatcher J. F., Altered lipid metabolism in brain injury and disorders. Subcellular Biochemistry 2008 49 241 268
59. Tapia-Arancibia L., Aliaga E., Silhol M., Arancibia S., New insights into brain BDNF function in normal aging and Alzheimer disease. Brain Research Reviews 2008 59 1 201 220 2-s2.0-53949111613 10.1016/j.brainresrev.2008.07.007
60. Kennedy K. M., Rodrigue K. M., Land S. J., Raz N., BDNF Val66Met polymorphism influences age differences in microstructure of the Corpus Callosum. Frontiers in Human Neuroscience 2009 3 19
61. Hota S. K., Barhwal K., Singh S. B., Ilavazhagan G., Chronic hypobaric hypoxia induced apoptosis in CA1 region of hippocampus: a possible role of NMDAR mediated p75NTR upregulation. Experimental Neurology 2008 212 1 5 13 2-s2.0-44649084915 10.1016/j.expneurol.2008.01.030
62. Langa K. M., Foster N. L., Larson E. B., Mixed dementia: emerging concepts and therapeutic implications. Journal of the American Medical Association 2004 292 23 2901 2908 2-s2.0-10344254833 10.1001/jama.292.23.2901
63. Korczyn A. D., Mixed dementia-the most common cause of dementia. Annals of the New York Academy of Sciences 2002 977 129 134 2-s2.0-0036452236
64. Jellinger K. A., Attems J., Neuropathological evaluation of mixed dementia. Journal of the Neurological Sciences 2007 257 1-2 80 87 2-s2.0-34249814045 10.1016/j.jns.2007.01.045
65. Jellinger K. A., Attems J., Is there pure vascular dementia in old age? Journal of the Neurological Sciences 2010 299 1-2 150 154 2-s2.0-78649507828 10.1016/j.jns.2010.08.038
66. Scheibel A. B., Duong T., Jacobs R., Alzheimer's disease as a capillary dementia. Annals of Medicine 1989 21 2 103 107 2-s2.0-0024375061
67. De La Torre J. C., Is Alzheimer's disease a neurodegenerative or a vascular disorder? Data, dogma, and dialectics. Lancet Neurology 2004 3 3 184 190 2-s2.0-1242331823 10.1016/S1474-4422(04)00683-0
68. Pluta R., Uamek M., Brain ischemia and ischemic blood-brain barier as etiological factors in sporadic Alzheimer's disease. Neuropsychiatric Disease and Treatment 2008 4 5 855 864 2-s2.0-56849119259
69. Zhang X., Zhou K., Wang R., Cui J., Lipton S. A., Liao F. F., Xu H., Zhang Y. W., Hypoxia-inducible factor 1 α (HIF-1 α)-mediated hypoxia increases BACE1 expression and β -amyloid generation. Journal of Biological Chemistry 2007 282 15 10873 10880 2-s2.0-34249727115 10.1074/jbc.M608856200
70. Kieda C., Greferath R., Da Silva C. C., Fylaktakidou K. C., Lehn J. M., Nicolau C., Suppression of hypoxia-induced HIF-1 α and of angiogenesis in endothelial cells by myo-inositol trispyrophosphate-treated erythrocytes. Proceedings of the National Academy of Sciences of the United States of America 2006 103 42 15576 15581 2-s2.0-33750350963 10.1073/pnas.0607109103
71. Biolo A., Greferath R., Siwik D. A., Qin F., Valsky E., Fylaktakidou K. C., Pothukanuri S., Duarte C. D., Schwarz R. P., Lehn J. M., Nicolau C., Colucci W. S., Enhanced exercise capacity in mice with severe heart failure treated with an allosteric effector of hemoglobin, myo-inositol trispyrophosphate. Proceedings of the National Academy of Sciences of the United States of America 2009 106 6 1926 1929 2-s2.0-60549097684 10.1073/pnas.0812381106
72. Lukiw W. J., Zhao Y., Jian G. C., An NF- κ B-sensitive micro RNA-146a-mediated inflammatory circuit in alzheimer disease and in stressed human brain cells. Journal of Biological Chemistry 2008 283 46 31315 31322 2-s2.0-57649119790 10.1074/jbc.M805371200
73. von Bernhardi R., Ramirez G., Toro R., Eugenin J., Pro-inflammatory conditions promote neuronal damage mediated by Amyloid Precursor Protein and decrease its phagocytosis and degradation by microglial cells in culture. Neurobiology of Disease 2007 26 1 153 164
74. Cole G. M., Morihara T., Lim G. P., Yang F., Begum A., Frautschy S. A., NSAID and antioxidant prevention of Alzheimer's disease: lessons from in vitro and animal models. Annals of the New York Academy of Sciences 2004 1035 68 84 2-s2.0-14944372848 10.1196/annals.1332.005
75. Munoz L., Ranaivo H., Roy S. M., Hu W., Craft J. M., McNamara L. K., Chico L. W., Van Eldik L. J., Watterson D. M., A novel p38 α MAPK inhibitor suppresses brain proinflammatory cytokine up-regulation and attenuates synaptic dysfunction and behavioral deficits in an Alzheimer's disease mouse model. Journal of Neuroinflammation 2007 4, article no. 21 2-s2.0-35348886061 10.1186/1742-2094-4-21
76. Lue L. F., Brachova L., Civin W. H., Rogers J., Inflammation, A β deposition, and neurofibrillary tangle formation as correlates of Alzheimer's disease neurodegeneration. Journal of Neuropathology and Experimental Neurology 1996 55 10 1083 1088 2-s2.0-0029795517
77. Lanzrein A. S., Johnston C. M., Perry V. H., Jobst K. A., King E. M., Smith A. D., Longitudinal study of inflammatory factors in serum, cerebrospinal fluid, and brain tissue in Alzheimer disease: interleukin-1 β interleukin-6, interleukin-1 receptor antagonist, tumor necrosis factor- α the soluble tumor necrosis factor receptors I and II, and α 1-antichymotrypsin. Alzheimer Disease and Associated Disorders 1998 12 3 215 227 2-s2.0-0032406078
78. Shepherd C. E., Thiel E., McCann H., Harding A. J., Halliday G. M., Cortical inflammation in Alzheimer disease but not dementia with Lewy bodies. Archives of Neurology 2000 57 6 817 822 2-s2.0-0034094213
79. Cutler R. G., Kelly J., Storie K., Pedersen W. A., Tammara A., Hatanpaa K., Troncoso J. C., Mattson M. P., Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease. Proceedings of the National Academy of Sciences of the United States of America 2004 101 7 2070 2075 2-s2.0-1242338183 10.1073/pnas.0305799101
80. Christen Y., Oxidative stress and Alzheimer disease. American Journal of Clinical Nutrition 2000 71 2 2-s2.0-0033954991
81. Tibolla G., Norata G. D., Meda C., Arnaboldi L., Uboldi P., Piazza F., Ferrarese C., Corsini A., Maggi A., Vegeto E., Catapano A. L., Increased atherosclerosis and vascular inflammation in APP transgenic mice with apolipoprotein E deficiency. Atherosclerosis 2010 210 1 78 87 2-s2.0-77952429592 10.1016/j.atherosclerosis.2009.10.040
82. Santpere G., Puig B., Ferrer I., Oxidative damage of 14-3-3 zeta and gamma isoforms in Alzheimer's disease and cerebral amyloid angiopathy. Neuroscience 2007 146 4 1640 1651 2-s2.0-34249314785 10.1016/j.neuroscience. 2007.03.013
83. Bowman G. L., Quinn J. F., Alzheimer's disease and the blood-brain barrier: past, present and future. Aging Health 2008 4 1 47 57 2-s2.0-39349083735 10.2217/1745509X.4.1.47
84. Carey B. J., Eames P. J., Blake M. J., Panerai R. B., Potter J. F., Dynamic cerebral autoregulation is unaffected by aging. Stroke 2000 31 12 2895 2900 2-s2.0-0033667185
85. Shim Y. S., Yang D. W., Kim B. S., Shon Y. M., Chung Y. A., Comparison of regional cerebral blood flow in two subsets of subcortical ischemic vascular dementia: statistical parametric mapping analysis of SPECT. Journal of the Neurological Sciences 2006 250 1-2 85 91 2-s2.0-33750504205 10.1016/j.jns.2006. 07.008
86. Schuff N., Matsumoto S., Kmiecik J., Studholme C., Du A., Ezekiel F., Miller B. L., Kramer J. H., Jagust W. J., Chui H. C., Weiner M. W., Cerebral blood flow in ischemic vascular dementia and Alzheimer's disease, measured by arterial spin-labeling magnetic resonance imaging. Alzheimer's and Dementia 2009 5 6 454 462 2-s2.0-71649102621 10.1016/j.jalz.2009.04.1233
87. Palhagen S. E., Ekberg S., Walinder J., Granerus A. K., Granerus G., HMPAO SPECT in Parkinson's disease (PD) with major depression (MD) before and after antidepressant treatment. Journal of Neurology 2009 256 9 1510 1518
88. Shimizu S., Hanyu H., Hirao K., Sato T., Iwamoto T., Koizumi K., Value of analyzing deep gray matter and occipital lobe perfusion to differentiate dementia with Lewy bodies from Alzheimer's disease. Annals of Nuclear Medicine 2008 22 10 911 916 2-s2.0-58249113848 10.1007/s12149-008-0193-5
89. Matsuda T., Abe T., Wu J. L., Fujiki M., Kobayashi H., Hypoxia-inducible factor-1 α DNA induced angiogenesis in a rat cerebral ischemia model. Neurological Research 2005 27 5 503 508 2-s2.0-22844441524 10.1179/ 016164105X25144
90. Patel N. S., Mathura V. S., Bachmeier C., Alzheimer's beta-amyloid peptide blocks vascular endothelial growth factor mediated signaling via direct interaction with VEGFR-2. Journal of Neurochemistry 2009 112 1 66 76
91. Solerte S. B., Ferrari E., Cuzzoni G., Locatelli E., Giustina A., Zamboni M., Schifino N., Rondanelli M., Gazzaruso C., Fioravanti M., Decreased release of the angiogenic peptide vascular endothelial growth factor in alzheimer's disease: recovering effect with insulin and DHEA sulfate. Dementia and Geriatric Cognitive Disorders 2005 19 1 1 10 2-s2.0-20844441406 10.1159/000080963
92. Borroni B., Ghezzi S., Agosti C., Archetti S., Fenoglio C., Galimberti D., Scarpini E., Di Luca M., Bresolin N., Comi G. P., Padovani A., Del Bo R., Preliminary evidence that VEGF genetic variability confers susceptibility to frontotemporal lobar degeneration. Rejuvenation Research 2008 11 4 773 780 2-s2.0-50449108723 10.1089/rej.2008.0711
93. Campbell I. L., Structural and functional impact of the transgenic expression of cytokines in the CNS. Annals of the New York Academy of Sciences 1998 840 83 96 2-s2.0-0032079013 10.1111/j.1749-6632.1998.tb09552.x
94. Ravaglia G., Forti P., Maioli F., Chiappelli M., Montesi F., Tumini E., Mariani E., Licastro F., Patterson C., Blood inflammatory markers and risk of dementia: the Conselice Study of Brain Aging. Neurobiology of Aging 2007 28 12 1810 1820 2-s2.0-35148823255 10.1016/j.neurobiolaging.2006.08.012
95. Hüll M., Strauss S., Berger M., Volk B., Bauer J., The participation of interleukin-6, a stress-inducible cytokine, in the pathogenesis of Alzheimer's disease. Behavioural Brain Research 1996 78 1 37 41 2-s2.0-0030014561 10.1016/0166-4328(95)00213-8
96. Silvestroni A., Faull R. L. M., Strand A. D., Möllera T., Distinct neuroinflammatory profile in post-mortem human Huntington's disease. NeuroReport 2009 20 12 1098 1103 2-s2.0-68249112361 10.1097/WNR.0b013e32832e34ee
97. Campuzano O., Castillo-Ruiz M. M., Acarin L., Castellano B., Gonzalez B., Increased levels of proinflammatory cytokines in the aged rat brain attenuate injury-induced cytokine response after excitotoxic damage. Journal of Neuroscience Research 2009 87 11 2484 2497 2-s2.0-70349256260 10.1002/jnr.22074
98. Pettigrew L. C., Kindy M. S., Scheff S., Springer J. E., Kryscio R. J., Li Y., Grass D. S., Focal cerebral ischemia in the TNFalpha-transgenic rat. Journal of Neuroinflammation 2008 5, article no. 47 2-s2.0-56449088071 10.1186/1742-2094-5-47
99. Zhao M., Cribbs D. H., Anderson A. J., Cummings B. J., Su J. H., Wasserman A. J., Cotman C. W., The induction of the TNF α death domain signaling pathway in Alzheimer's disease brain. Neurochemical Research 2003 28 2 307 318 2-s2.0-0037289757 10.1023/A:1022337519035
100. Licastro F., Chiappelli M., Ruscica M., Carnelli V., Corsi M. M., Altered cytokine and acute phase response protein levels in the blood of children with Downs syndrome, relationship with dementia of Alzheimer's type. International Journal of Immunopathology and Pharmacology 2005 18 1 165 172
101. Mogi M., Harada M., Riederer P., Narabayashi H., Fujita K., Nagatsu T., Tumor necrosis factor- α (TNF- α) increases both in the brain and in the cerebrospinal fluid from parkinsonian patients. Neuroscience Letters 1994 165 1-2 208 210 2-s2.0-0028178281 10.1016/0304-3940(94)90746-3
102. Brionne T. C., Tesseur I., Masliah E., Wyss-Coray T., Loss of TGF- β 1 leads to increased neuronal cell death and microgliosis in mouse brain. Neuron 2003 40 6 1133 1145 2-s2.0-0347362913 10.1016/S0896-6273(03)00766-9
103. Krupinski J., Kumar P., Kumar S., Kaluza J., Increased expression of TGF- β 1 in brain tissue after ischemic stroke in humans. Stroke 1996 27 5 852 857 2-s2.0-0029879741
104. Blasko I., Stampfer-Kountchev M., Robatscher P., Veerhuis R., Eikelenboom P., Grubeck-Loebenstein B., How chronic inflammation can affect the brain and support the development of Alzheimer's disease in old age: the role of microglia and astrocytes. Aging Cell 2004 3 4 169 176 2-s2.0-13844281550 10.1111/j.1474-9728.2004.00101.x
105. Wyss-Coray T., Masliah E., Mallory M., McConlogue L., Johnson-Wood K., Lin C., Mucke L., Amyloidogenic role of cytokine TGF- β 1 in transgenic mice and in Alzheimer's disease. Nature 1997 389 6651 603 606 2-s2.0-0030764732 10.1038/39321
106. Ewers M., Mielke M. M., Hampel H., Blood-based biomarkers of microvascular pathology in Alzheimer's disease. Experimental Gerontology 2009 45 1 75 79
107. Peter K., Nawroth P., Conradt C., Circulating vascular cell adhesion molecule-1 correlates with the extent of human atherosclerosis in contrast to circulating intercellular adhesion molecule-1, E-selectin, P-selectin, and thrombomodulin. Arteriosclerosis, Thrombosis, and Vascular Biology 1997 17 3 505 512
108. Fassbender K., Bertsch T., Mielke O., Mühlhauser; F., Hennerici M., Adhesion molecules in cerebrovascular diseases: evidence for an inflammatory endothelial activation in cerebral large- and small-vessel disease. Stroke 1999 30 8 1647 1650 2-s2.0-0032788005
109. Smith C. D., Carney J. M., Starke-Reed P. E., Oliver C. N., Stadtman E. R., Floyd R. A., Markesbery W. R., Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease. Proceedings of the National Academy of Sciences of the United States of America 1991 88 23 10540 10543 2-s2.0-0025790342
110. Choi K., Kim J., Kim G. W., Chulhee C., Oxidative stress-induced necrotic cell death via mitochondira-dependent burst of reactive oxygen species. Current Neurovascular Research 2009 6 4 213 222 2-s2.0-70350325187 10.2174/ 156720209789630375
111. Shi Q., Gibson G. E., Oxidative stress and transcriptional regulation in Alzheimer disease. Alzheimer Disease and Associated Disorders 2007 21 4 276 291 2-s2.0-37349049243 10.1097/WAD.0b013e31815721c3
112. Esteves A. R., Arduino D. M., Swerdlow R. H., Oliveira C. R., Cardoso S. M., Oxidative stress involvement in alpha-synuclein oligomerization in Parkinson's disease cybrids. Antioxidants and Redox Signaling 2009 11 3 439 448
113. Miller R. L., James-Kracke M., Sun G. Y., Sun A. Y., Oxidative and inflammatory pathways in Parkinson's disease. Neurochemical Research 2009 34 1 55 65 2-s2.0-58149466868 10.1007/s11064-008-9656-2
114. Yehuda S., Rabinovitz S., Carasso R. L., Mostofsky D. I., The role of polyunsaturated fatty acids in restoring the aging neuronal membrane. Neurobiology of Aging 2002 23 5 843 853 2-s2.0-0036752552 10.1016/S0197-4580(02) 00074-X
115. Recuero M., Vicente M. C., Martínez-García A., Ramos M. C., Carmona-Ssaez P., Sastre I., Aldudo J., Vilella E., Frank A., Bullido M. J., Valdivieso F., A free radical-generating system induces the cholesterol biosynthesis pathway: a role in Alzheimer's disease. Aging Cell 2009 8 2 128 139 2-s2.0-63549095100 10.1111/j.1474-9726.2009.00457.x
116. Jasinska-Myga B., Opala G., Goetz C. G., Tustanowski J., Ochudlo S., Gorzkowska A., Tyrpa J., Apolipoprotein E gene polymorphism, total plasma cholesterol level, and Parkinson disease dementia. Archives of Neurology 2007 64 2 261 265 2-s2.0-33847007700 10.1001/archneur.64.2.261
117. Ferreiro E., Resende R., Costa R., Oliveira C. R., Pereira C. M. F., An endoplasmic-reticulum-specific apoptotic pathway is involved in prion and amyloid-beta peptides neurotoxicity. Neurobiology of Disease 2006 23 3 669 678 2-s2.0-33747195017 10.1016/j.nbd.2006.05.011
118. Beal M. F., Excitotoxicity and nitric oxide in Parkinson's disease pathogenesis. Annals of Neurology 1998 44 3 supplement 1 S110 S114
119. Tang T. S., Slow E., Lupu V., Stavrovskaya I. G., Sugimori M., Llinás R., Kristal B. S., Hayden M. R., Bezprozvanny I., Disturbed Ca2+ signalling and apoptosis of medium spiny neurons in Huntington's disease. Proceedings of the National Academy of Sciences of the United States of America 2005 102 7 2602 2607 2-s2.0-14044264256 10.1073/pnas.0409402102
120. Raza M., Deshpande L. S., Blair R. E., Carter D. S., Sombati S., DeLorenzo R. J., Aging is associated with elevated intracellular calcium levels and altered calcium homeostatic mechanisms in hippocampal neurons. Neuroscience Letters 2007 418 1 77 81 2-s2.0-34247115505 10.1016/j.neulet.2007.03.005
121. Webster M. J., Herman M. M., Kleinman J. E., Shannon Weickert C., BDNF and trkB mRNA expression in the hippocampus and temporal cortex during the human lifespan. Gene Expression Patterns 2006 6 8 941 951 2-s2.0-33748134645 10.1016/j.modgep.2006.03.009
122. Marini A. M., Choi J., Labutta R., Synaptic deprivation and age-related vulnerability to hypoxic-ischemic neuronal injury: a hypothesis. Annals of the New York Academy of Sciences 2001 939 238 253 2-s2.0-0034944621
123. Walton M., Connor B., Lawlor P., Young D., Sirimanne E., Gluckman P., Cole G., Dragunow M., Neuronal death and survival in two models of hypoxic-ischemic brain damage. Brain Research Reviews 1999 29 2-3 137 168 2-s2.0-0032956368 10.1016/S0165-0173(98)00053-8
124. Phillips H. S., Hains J. M., Armanini M., Laramee G. R., Johnson S. A., Winslow J. W., BDNF mRNA is decreased in the hippocampus of individuals with Alzheimer's disease. Neuron 1991 7 5 695 702 2-s2.0-0025993361 10.1016/0896-6273(91)90273-3
125. Howells D. W., Porritt M. J., Wong J. Y. F., Batchelor P. E., Kalnins R., Hughes A. J., Donnan G. A., Reduced BDNF mRNA expression in the Parkinson's disease substantia nigra. Experimental Neurology 2000 166 1 127 135 2-s2.0-0033762265 10.1006/exnr.2000.7483
126. Parain K., Murer M. G., Yan Q., Faucheux B., Agid Y., Hirsch E., Raisman-Vozari R., Reduced expression of brain-derived neurotrophic factor protein in Parkinson's disease substantia nigra. NeuroReport 1999 10 3 557 561 2-s2.0-0033602009
127. Bull R., Finkelstein J. P., Galvez J., Ischemia enhances activation by Ca2+ and redox modification of ryanodine receptor channels from rat brain cortex. The Journal of Neuroscience 2008 28 38 9463 9472